Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025 GlobeNewswire December 01, 2025 Geneva, Switzerland, December 1, 2025 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it […]